Erdafitinib Intravesical Delivery System
CR109115
Phase 2 small_molecule active
Quick answer
Erdafitinib Intravesical Delivery System for Non-Muscle Invasive Bladder Neoplasms is a Phase 2 program (small_molecule) at Janssen Cilag International NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen Cilag International NV
- Indication
- Non-Muscle Invasive Bladder Neoplasms
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active